EAM Investors’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-73,226
Closed -$2.49M 324
2022
Q3
$2.49M Sell
73,226
-11,287
-13% -$417K 0.54% 61
2022
Q2
$2.46M Buy
+84,513
New +$2.15M 0.6% 43
2021
Q3
Sell
-40,520
Closed -$1.8M 367
2021
Q2
$1.8M Buy
+40,520
New +$1.5M 0.28% 154

Other funds holding PRVA

EAM Investors's PRVA Position: Q4 2022 in Review

EAM Investors sold out of Privia Health (PRVA) in Q4 2022, closing a stake of 73,226 shares — an estimated $2.49M sold.

EAM Investors first reported a position in PRVA in Q2 2021 and held it in 3 quarters. The position peaked at $2.49M in Q3 2022. 192 funds tracked by Wall St. Rank hold PRVA as of Q4 2022.

  • EAM Investors reported no remaining Privia Health position as of Q4 2022 after selling out during the quarter.
  • EAM Investors sold 73,226 Privia Health shares in Q4 2022, an estimated $2.49M.
  • EAM Investors first reported a position in Privia Health in Q2 2021 and held it in 3 quarters.
  • EAM Investors's Privia Health position peaked at $2.49M in Q3 2022.
  • 192 funds tracked by Wall St. Rank held Privia Health as of Q4 2022.

Based on EAM Investors's 13F filing for Q4 2022, filed 14 Feb 2023.